Hallym University Sacred Heart Hospital Reports Findings in Gastric Cancer (Multicenter phase Ib/II study of second-line durvalumab and tremelimumab in combination with paclitaxel in patients with biomarker-selected metastatic gastric cancer)

Press/Media: Press / Media

Period2025 Jun 3

Media coverage

1

Media coverage

  • TitleHallym University Sacred Heart Hospital Reports Findings in Gastric Cancer (Multicenter phase Ib/II study of second-line durvalumab and tremelimumab in combination with paclitaxel in patients with biomarker-selected metastatic gastric cancer)
    Media name/outletSouth Korea Daily Report
    Country/TerritoryUnited States
    Date25/6/3
    PersonsWon-Ki Kim, Jin Kim, Jin Kim